With considerable drug development efforts underway for anti-cancer ACKR3 therapeutics [20] and the potential to target other disorders, including brain diseases [21–26] there is the need for improved tools to study ACKR3 ex vivo and in vivo [27]. This evidence concerns the gene ACKR3 and brain disorder.